swissethics
Study ID, Version xx of date (DD/MM/YYYY) Page 3 of 45 <<Protocol template: Interventional study with investigational medicinal product (IMP) / medical device (MD)>> Clinical Study Protocol
Download swissethics
Information
Domain:
Source:
Link to this page:
Related documents
2009 06 annex13 - ECA Academy
academy.gmp-compliance.orgPRINCIPLE Investigational medicinal products should be produced in accordance with the principles and the detailed guidelines of Good Manufacturing Practice for Medicinal Products (The Rules
First in Human Studies - ABPI
www.abpi.org.ukIntroduction First in Human (FIH) clinical trials are part of the exploratory phase of drug development and represent a significant milestone in the clinical development of new
Thomas Sudhop, MD - AGAH
www.agah.eu2 3 Required IMP related Data Investigator’s brochure Trial Protocol Investigational Medicinal Product Dossier (IMPD) Examples of the label in the national language
Guideline on the requirements for quality …
www.ema.europa.euGuidelineontherequirementsforqualitydocumentationconcerningbiological investigationalmedicinalproductsinclinicaltrials EMA/CHMP/BWP/534898/2008 Page 3/17
Guideline on strategies to identify and mitigate …
www.ema.europa.euThe purpose of FIH trials is to evaluate an investigational medicinal product ( IMP) in humans for the first time, to study the human pharmacology , tolerability and safety of the IMP and to compare how
DIRECTIVE FOR IMPORTATION AND RELEASE OF …
www.who.intdraft template document [name of national regulatory authority] directive for importation and release of investigational medicinal products for clinical trials to be conducted in (name of the country)
The new Clinical Trial Regulation and corresponding …
dgra.deTITLE PAGE The new Clinical Trial Regulation and corresponding new EU portal and database: an opportunity to enhance standardisation and interoperability in …
Labelling Requirements for Investigational …
dgra.deLabelling Requirements for Investigational Medicinal Products in Multinational Clinical Trials: Bureaucratic Cost Driver or Added Value? Wissenschaftliche Prüfungsarbeit